• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    AbbVie Inc. (ABBV)

    -NYSE
    53.48 Up 0.59(1.12%) Feb 9, 4:00PM EST
    |After Hours : 53.48 0.00 (0.00%) Feb 9, 5:02PM EST
    Prev Close:52.89
    Open:52.31
    Bid:53.07 x 200
    Ask:53.79 x 200
    1y Target Est:72.81
    Beta:1.59589
    Earnings Date:Apr 21 - Apr 25 (Est.)
    Day's Range:52.06 - 53.94
    52wk Range:45.45 - 71.60
    Volume:7,655,796
    Avg Vol (3m):8,888,640
    Market Cap:87.43B
    P/E (ttm):17.09
    EPS (ttm):3.13
    Div & Yield:2.28 (4.29%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVUp 1.12%87.43B
    PFEUp 1.89%179.65B
    MRKUp 0.68%137.33B

    Key Statistics

    Forward P/E (1 yr):8.97
    P/S (ttm):3.78
    Ex-Dividend Date:13-Jan-16

    Analysts

    Annual EPS Est (Dec-16) :5.02
    Quarterly EPS Est (Mar-16) :1.14
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):0.58

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback